Intensive chemotherapy dramatically improves recurrence and survival in ...
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years later, compared with patients ...
Intensified Immunochemotherapy Benefits B-Cell LymphomaDoctors Lounge
Intense Chemo Best for Aggressive LymphomaMedscape

all 4 news articles »